Overview of extracellular vesicles as biomarkers and therapeutic tools in pediatric diseases: focus on the gut-lung axis

Abstract

Although anatomically separate, the gut and lungs are interconnected through intricate pathways involving their respective microbiota, supporting the concept of a gut-lung axis. In the pediatric field, devastating intestinal pathologies such as necrotizing enterocolitis and inflammatory bowel diseases mostly affect preterm infants. In parallel, in the lung, bronchopulmonary dysplasia and chronic obstructive pulmonary disease represent pediatric unmet clinical needs. In this review, we discuss how the extracellular vesicles (EVs), nanoparticles secreted by all cell types, represent a common element in the gut-lung axis. Specifically, EVs play a dual role, serving both as novel disease biomarkers and as promising therapeutic agents.

Keywords

Gut / lung / extracellular vesicles / inflammatory bowel disease / necrotizing enterocolitis / bronchopulmonary dysplasia / chronic obstructive pulmonary disease

References

[1] Kalluri R.The biology, function, and biomedical applications of exosomes.Science2020;367:eaau6977 PMCID:PMC7717626

[2] Yáñez-Mó M,Andreu Z.Biological properties of extracellular vesicles and their physiological functions.J Extracell Vesicles2015;4:27066 PMCID:PMC4433489

[3] Mathieu M,Lavieu G.Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication.Nat Cell Biol2019;21:9-17

[4] Raposo G.Extracellular vesicles: exosomes, microvesicles, and friends.J Cell Biol2013;200:373-83 PMCID:PMC3575529

[5] Kowal J,Théry C.Biogenesis and secretion of exosomes.Curr Opin Cell Biol2014;29:116-25

[6] Buzás EI,Sódar BW.Molecular interactions at the surface of extracellular vesicles.Semin Immunopathol2018;40:453-64 PMCID:PMC6208672

[7] Schorey JS,Singh PP.Exosomes and other extracellular vesicles in host-pathogen interactions.EMBO Rep2015;16:24-43 PMCID:PMC4304727

[8] Robbins PD.Regulation of immune responses by extracellular vesicles.Nat Rev Immunol2014;14:195-208 PMCID:PMC4350779

[9] Andaloussi S, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities.Nat Rev Drug Discov2013;12:347-57

[10] Vader P,Pasterkamp G.Extracellular vesicles for drug delivery.Adv Drug Deliv Rev2016;106:148-56

[11] Marsland BJ,Gollwitzer ES.The gut-lung axis in respiratory disease.Ann Am Thorac Soc2015;12:S150-6

[12] Dang AT.Microbes, metabolites, and the gut-lung axis.Mucosal Immunol2019;12:843-50

[13] He C,Luo Y.Exosome theranostics: biology and translational medicine.Theranostics2018;8:237-55 PMCID:PMC5743472

[14] Budden KF,Wood DL.Emerging pathogenic links between microbiota and the gut-lung axis.Nat Rev Microbiol2017;15:55-63

[15] Dumas A,Poquet Y,Neyrolles O.The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.Cell Microbiol2018;20:e12966

[16] Jia H,Yamaguchi Y.Toll like receptor 4 mediated lymphocyte imbalance induces nec-induced lung injury.Shock2019;52:215-23 PMCID:PMC6387863

[17] Jia H,Yamaguchi Y.Pulmonary epithelial TLR4 activation leads to lung injury in neonatal necrotizing enterocolitis.J Immunol2016;197:859-71 PMCID:PMC4955761

[18] Zeng B,Khan N.Yin-Yang: two sides of extracellular vesicles in inflammatory diseases.J Nanobiotechnology2024;22:514 PMCID:PMC11351009

[19] Lee M.Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues.Gastroenterology2021;160:524-37 PMCID:PMC8098834

[20] Metwali A,Ince MN.Recirculating immunocompetent cells in colitic mice intensify their lung response to bacterial endotoxin.Dig Dis Sci2018;63:2930-9 PMCID:PMC6182434

[21] Eladham MW,Sekar P.The role of gut leakage and immune cell miss-homing on gut dysbiosis-induced lung inflammation in a DSS mice model.PLoS One2025;20:e0324230 PMCID:PMC12118880

[22] Shen Q,Yao J.Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease.J Adv Res2022;37:221-33 PMCID:PMC9039646

[23] Hou JJ,Wang XL,Qin YH.Efficacy of extracellular vesicles as a cell-free therapy in colitis: a systematic review and meta-analysis of animal studies.Front Pharmacol2023;14:1260134 PMCID:PMC10637393

[24] Leoni G,Kamaly N.Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.J Clin Invest2015;125:1215-27 PMCID:PMC4362251

[25] Park YE,Yong D.Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases.Sci Rep2022;12:6359 PMCID:PMC9012770

[26] Zheng X,Zhang Q.Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease.Protein Cell2017;8:686-95 PMCID:PMC5563283

[27] Galley JD,Wang Y,Rajab A.Urine-derived extracellular vesicle miRNAs as possible biomarkers for and mediators of necrotizing enterocolitis: A proof of concept study.J Pediatr Surg2021;56:1966-75 PMCID:PMC8410893

[28] Gunasekaran A,Levin S.Biomarkers of necrotizing enterocolitis: the search continues.Clin Perinatol2022;49:181-94

[29] Mao F,Tang X.Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice.Biomed Res Int2017;2017:5356760 PMCID:PMC5447283

[30] Yang R,Cui S,Zhang T.IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b.Cell Death Dis2020;11:603 PMCID:PMC7393506

[31] Tolomeo AM,Piccoli M.Extracellular vesicles secreted by mesenchymal stromal cells exert opposite effects to their cells of origin in murine sodium dextran sulfate-induced colitis.Front Immunol2021;12:627605 PMCID:PMC8076641

[32] Duan L,Zhao X.Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress.Int J Mol Med2020;46:1551-61 PMCID:PMC7447323

[33] Appiah MG,Darkwah S.Intestinal epithelium-derived luminally released extracellular vesicles in sepsis exhibit the ability to suppress TNF-α and IL-17A expression in mucosal inflammation.Int J Mol Sci2020;21:8445 PMCID:PMC7696152

[34] Filler R,Li B.Bovine milk-derived exosomes attenuate NLRP3 inflammasome and NF-κB signaling in the lung during neonatal necrotizing enterocolitis.Pediatr Surg Int2023;39:211

[35] Gupta S,Soni N,Banerjee A.Comparative proteomic profiling of small extracellular vesicles derived from iPSCs and tissue specific mesenchymal stem cells.Exp Cell Res2022;420:113354

[36] Zeng R,Zhuo Z,Sha W.Stem cells and exosomes: promising candidates for necrotizing enterocolitis therapy.Stem Cell Res Ther2021;12:323 PMCID:PMC8180168

[37] Matei AC,Zani A.Extracellular vesicles as a potential therapy for neonatal conditions: state of the art and challenges in clinical translation.Pharmaceutics2019;11:404 PMCID:PMC6723449

[38] Filip R.An update on the role of extracellular vesicles in the pathogenesis of necrotizing enterocolitis and inflammatory bowel diseases.Cells2021;10:3202 PMCID:PMC8622309

[39] Maghraby MK,Chi L.Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition.Sci Rep2021;11:7635 PMCID:PMC8026962

[40] Good M,Sodhi CP.Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium.Proc Natl Acad Sci U S A2012;109:11330-5 PMCID:PMC3396489

[41] Rager TM,Zhou Y,Besner GE.Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis.J Pediatr Surg2016;51:942-7 PMCID:PMC4921266

[42] Bonadies L,Porzionato A,Muraca M.Present and future of bronchopulmonary dysplasia.J Clin Med2020;9:1539 PMCID:PMC7290764

[43] Kumar MA,Sadida HQ.Extracellular vesicles as tools and targets in therapy for diseases.Signal Transduct Target Ther2024;9:27 PMCID:PMC10838959

[44] Principi N,Esposito S.Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies.J Transl Med2018;16:36 PMCID:PMC5819643

[45] Bush A.COPD: a pediatric disease.COPD2008;5:53-67

[46] Fischer BM,Voynow JA.Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation.Int J Chron Obstruct Pulmon Dis2011;6:413-21 PMCID:PMC3157944

[47] Lomas DA.Does protease-antiprotease imbalance explain chronic obstructive pulmonary disease?.Ann Am Thorac Soc2016;13:S130-7

[48] Lin S,Huang Y,Yi H.Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.Mol Immunol2022;141:87-93

[49] Toraldo DM.Influence of the lung microbiota dysbiosis in chronic obstructive pulmonary disease exacerbations: the controversial use of corticosteroid and antibiotic treatments and the role of eosinophils as a disease marker.J Clin Med Res2019;11:667-75 PMCID:PMC6785281

[50] Camilleri M.Leaky gut: mechanisms, measurement and clinical implications in humans.Gut2019;68:1516-26 PMCID:PMC6790068

[51] Li Y,Zhao Q.Microbial and metabolic profiles of bronchopulmonary dysplasia and therapeutic effects of potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidum.J Appl Microbiol2022;133:908-21

[52] Kotlyarov S.Role of short-chain fatty acids produced by gut microbiota in innate lung immunity and pathogenesis of the heterogeneous course of chronic obstructive pulmonary disease.Int J Mol Sci2022;23:4768 PMCID:PMC9099629

[53] Wu J,Chen Y.Extracellular vesicles and COPD: foe or friend?.J Nanobiotechnology2023;21:147 PMCID:PMC10161449

[54] Di Gioia S, Daniello V, Conese M. Extracellular vesicles’ role in the pathophysiology and as biomarkers in cystic fibrosis and COPD.Int J Mol Sci2023;24:228 PMCID:PMC9820204

[55] Nieri D,Lombardi S.Circulating extracellular vesicles are associated with disease severity and interleukin-6 levels in COPD: a pilot study.J Clin Med2021;10:5014 PMCID:PMC8584816

[56] Guo Y,Zhu W.Hsa_circ_0001359 in serum exosomes: a promising marker to predict bronchopulmonary dysplasia in premature infants.J Inflamm Res2024;17:5025-37 PMCID:PMC11287472

[57] Chen W,Thorman A.Extracellular vesicles and preterm infant diseases.Front Pediatr2025;13:1550115 PMCID:PMC11873092

[58] Zhong X qi,Zhu Q jiong.Umbilical cord blood exosomes from very preterm infants with bronchopulmonary dysplasia aggravate lung injury in mice.Sci Rep2023;13:8648 PMCID:PMC10224930

[59] Al-Humiari MA,Liu LP.Extracellular vesicles from BALF of pediatric cystic fibrosis and asthma patients increase epithelial sodium channel activity in small airway epithelial cells.Biochim Biophys Acta Biomembr2024;1866:184219 PMCID:PMC11632644

[60] Ransom MA,Negretti NM.Developmental trajectory of extracellular vesicle characteristics from the lungs of preterm infants.Am J Physiol Lung Cell Mol Physiol2023;324:L385-92 PMCID:PMC10026990

[61] Lacedonia D,Trotta T.Microparticles in sputum of COPD patients: a potential biomarker of the disease?.Int J Chron Obstruct Pulmon Dis2016;11:527-33 PMCID:PMC4798204

[62] Nieri D,De Francesco M.Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.Respir Med2024;223:107563

[63] Burke H,Freeman A.Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD.Front Med2022;9:1039702 PMCID:PMC9797812

[64] Dellago H,Terlecki-Zaniewicz L.High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan.Aging Cell2013;12:446-58 PMCID:PMC3864473

[65] Xu H,Xue J.Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking.Theranostics2018;8:5419-33 PMCID:PMC6276085

[66] Worthington EN.Therapeutic use of extracellular vesicles for acute and chronic lung disease.Int J Mol Sci2020;21:2318 PMCID:PMC7177288

[67] Abreu SC,Rocco PR.Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?.Stem Cell Res Ther2016;7:53 PMCID:PMC4831172

[68] Fujita Y,Araya J,Kuwano K.Clinical application of mesenchymal stem cell-derived extracellular vesicle-based therapeutics for inflammatory lung diseases.J Clin Med2018;7:355 PMCID:PMC6210470

[69] Bellio MA,Milberg J.Amniotic fluid-derived extracellular vesicles: characterization and therapeutic efficacy in an experimental model of bronchopulmonary dysplasia.Cytotherapy2021;23:1097-107

[70] Tieu A,Gnyra C.Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: a meta-analysis.J Extracell Vesicles2021;10:e12141 PMCID:PMC8485337

[71] Lesage F.Mesenchymal stromal cell-derived extracellular vesicles for neonatal lung disease: tiny particles, major promise, rigorous requirements for clinical translation.Cells2022;11:1176 PMCID:PMC8997376

[72] Willis GR,Anastas J.Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation.Am J Respir Crit Care Med2018;197:104-16 PMCID:PMC5765387

[73] Porzionato A,Dedja A.Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia.Am J Physiol Lung Cell Mol Physiol2019;316:L6-19

[74] Bisaccia P,D’Agostino S.Extracellular vesicles from mesenchymal umbilical cord cells exert protection against oxidative stress and fibrosis in a rat model of bronchopulmonary dysplasia.Stem Cells Transl Med2024;13:43-59 PMCID:PMC10785219

[75] Albertine KH,Dawson E.Mesenchymal stromal cell extracellular vesicles improve lung development in mechanically ventilated preterm lambs.Am J Physiol Lung Cell Mol Physiol2024;326:L770-85 PMCID:PMC11380989

[76] Sharma M,Benny M.Mesenchymal stem cell-derived extracellular vesicles prevent experimental bronchopulmonary dysplasia complicated by pulmonary hypertension.Stem Cells Transl Med2022;11:828-40 PMCID:PMC9397655

[77] Wu Y,Yuan R,Wu X.Bone marrow mesenchymal stem cell-derived exosomes alleviate hyperoxia-induced lung injury via the manipulation of microRNA-425.Arch Biochem Biophys2021;697:108712

[78] Tang XD,Monsel A.Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA.Stem Cells2017;35:1849-59

[79] Serban KA,Petrusca DN.Structural and functional characterization of endothelial microparticles released by cigarette smoke.Sci Rep2016;6:31596 PMCID:PMC4987682

[80] Harrell CR,Sadikot R.Molecular and cellular mechanisms responsible for beneficial effects of mesenchymal stem cell-derived product “Exo-d-MAPPS” in attenuation of chronic airway inflammation.Anal Cell Pathol2020;2020:3153891 PMCID:PMC7109559

[81] Zhai Z,Chen J,Zhang T.Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment.J Transl Med2023;21:895 PMCID:PMC10709966

[82] Kang J,Wu X.Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases.Front Cell Dev Biol2024;12:1271684 PMCID:PMC11035777

[83] Pu Q,Gao P.Gut microbiota regulate gut-lung axis inflammatory responses by mediating ILC2 compartmental migration.J Immunol2021;207:257-67 PMCID:PMC8674377

[84] Hou K,Chen XY.Microbiota in health and diseases.Signal Transduct Target Ther2022;7:135 PMCID:PMC9034083

[85] Kim HJ,Kim KH.The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients.Exp Mol Med2017;49:e316 PMCID:PMC5420800

[86] Zhao S,Fan H.Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications.Mol Biomed2024;5:60 PMCID:PMC11579273

[87] Welsh JA, Goberdhan DCI, O’Driscoll L, et al; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404. PMCID:PMC10850029